Pharma: Research Access
Discover Taylor & Francis Pharmaceutical Content for the Latest Research and Information
Here Are 5 FREE Articles On Us!
Taylor & Francis are publishers of quality, peer-reviewed journals. Enhance your research and development with the most current information and opportunities in the pharmaceutical industry.
Research Access Options
Taylor & Francis offers tailored solutions to organization's needs including Article Pass and Subscription services. Taylor & Francis also offer single journal issues, individual articles, and archived journal volumes as well as flexible pay-per-view options.
About Article Pass
Article Pass is a pre-paid token system designed to provide savings of between 15 and 50% on the price of individual journals.
Article Pass is valid for 12 months after the time of purchase, articles will be available across your organization's server for a total of 24 hours from initial selection. Articles are also available for PDF download for personal use, as well as several other benefits, including:
- Substantial savings of 15 to 50% on the individual article price
- Meeting your research needs: choose articles from over 2500 journals within 23 subject areas
- Flexibility: cover as little as 50 articles or as many as 2000
- Budget control: Article Pass includes a "mediated access" option enabling you to restrict use to specific individuals within your organization so only these approved users can use the Article Pass.
With Subscriptions, you can ensure your colleagues have access to the research covering all aspects of the R&D pipeline. Tailor your collection on a title-by-title basis, choosing from more than 2500 journals and over 4.1 million articles.
Choose from subscriptions with combined print and online access, or opt for online-only access.
A full list of our journals can be found on Taylor & Francis Online.
Taylor & Francis' Top Pharma Research Titles
Find out more about leading pharmaceutical research from drug discovery to clinical trial evaluations including the world's largest series review journals in R&D and clinical medicine.
Current Medical Research and Opinion
A MEDLINE-indexed, peer-reviewed, international journal for the publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations.
2017 Impact Factor: 2.665
Expert Review of Vaccines
A MEDLINE-indexed peer-reviewed journal providing expert commentary on the development, application, and clinical effectiveness of new vaccines. Topics include vaccine technology, vaccine adjuvants, prophylactic vaccines, and therapeutic vaccines.
2017 Impact Factor: 4.271
Journal of Medical Economics
Serving the international pharmacoeconomics and healthcare-research community, it publishes economic assessments of novel therapeutic and device interventions, along-side studies that measure therapeutic or preventative outcomes, and policy issues.
Impact Factor: 2.264
Critical Reviews in Toxicology
This journal provides up-to-date, objective analyses of topics related to the mechanisms of action, responses, and assessment of health risks due to toxicant exposure.
2017 Impact Factor: 5.313
Expert Opinion on Drug Delivery
Providing comprehensive coverage of drug delivery research, including delivery technologies, vehicles, formulations and devices, the delivery of specific drug and therapeutic classes, modes of entry into the body, and applications in diseases.
2017 Impact Factor: 5.553
Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. This high-profile journal specifically deals with tumor immunology.
2017 Impact Factor: 2.665
Discover our Expert Collection
The Expert Collection is the world's largest series of review journals in research, development and clinical medicine. It is comprised of 29 peer-reviewed titles combining the well-established Expert Opinion and Expert Reviews series into one essential, comprehensive collection.Find out more